The Global Medical Blood Lancet Market is on a robust growth trajectory, fundamentally supported by the unstoppable rise of chronic diseases and the global trend toward patient-centric, home-based care. While the core driver is the diabetes epidemic, the market’s future lies in its ability to evolve from a commodity to a connected health device.
